|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US4230705A
(en)
|
1976-09-22 |
1980-10-28 |
American Cyanamid Company |
6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
|
|
CA1080712A
(en)
|
1976-09-22 |
1980-07-01 |
Jay D. Albright |
Hypotensive agents
|
|
US4112095A
(en)
|
1976-10-07 |
1978-09-05 |
American Cyanamid Company |
6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents
|
|
US4242515A
(en)
|
1979-03-28 |
1980-12-30 |
American Cyanamid Company |
Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
US5364620A
(en)
|
1983-12-22 |
1994-11-15 |
Elan Corporation, Plc |
Controlled absorption diltiazem formulation for once daily administration
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US4902514A
(en)
|
1988-07-21 |
1990-02-20 |
Alza Corporation |
Dosage form for administering nilvadipine for treating cardiovascular symptoms
|
|
GB9507348D0
(en)
|
1995-04-08 |
1995-05-31 |
Knoll Ag |
Therapeutic agents
|
|
WO2002006286A2
(en)
*
|
2000-07-14 |
2002-01-24 |
Bristol-Myers Squibb Pharma Company |
IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
|
|
WO2006061428A2
(en)
|
2004-12-10 |
2006-06-15 |
Universität Zürich |
Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain
|
|
US20100088778A1
(en)
|
2005-06-16 |
2010-04-08 |
John Charles Mulley |
Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene
|
|
HUE030390T2
(en)
*
|
2005-12-21 |
2017-05-29 |
Janssen Pharmaceutica Nv |
Triazolopyridazines as tyrosine kinase modulators
|
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
PE20080403A1
(es)
|
2006-07-14 |
2008-04-25 |
Amgen Inc |
Derivados heterociclicos fusionados y metodos de uso
|
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
KR100858357B1
(ko)
|
2006-10-02 |
2008-09-11 |
(주) 디지탈바이오텍 |
벤조퓨란계 유도체 화합물을 유효성분으로 함유하는인지기능 장애의 예방 및 치료용 조성물
|
|
FR2915198B1
(fr)
|
2007-04-18 |
2009-12-18 |
Sanofi Aventis |
Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
|
|
CA2713521A1
(en)
|
2008-02-06 |
2009-08-13 |
Gilead Palo Alto, Inc. |
Use of ranolazine for treating pain
|
|
WO2010053757A1
(en)
|
2008-10-29 |
2010-05-14 |
Gilead Palo Alto, Inc. |
2 -oxoquinoxalin blockers of the late sodium channel
|
|
WO2010074807A1
(en)
|
2008-10-30 |
2010-07-01 |
Gilead Palo Alto, Inc. |
3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
|
|
US20100125091A1
(en)
|
2008-11-14 |
2010-05-20 |
Gilead Palo Alto, Inc. |
Substituted heterocyclic compounds as ion channel modulators
|
|
JP5657566B2
(ja)
|
2008-12-24 |
2015-01-21 |
バイアル ポルテラ アンド シーエイ エス エイＢＩＡＬ−Ｐｏｒｔｅｌａ ＆ Ｃａ， Ｓ．Ａ． |
医薬品
|
|
CN102439008B
(zh)
|
2009-05-12 |
2015-04-29 |
杨森制药有限公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
|
|
US8952034B2
(en)
|
2009-07-27 |
2015-02-10 |
Gilead Sciences, Inc. |
Fused heterocyclic compounds as ion channel modulators
|
|
WO2011056985A2
(en)
|
2009-11-04 |
2011-05-12 |
Gilead Sciences, Inc. |
Substituted heterocyclic compounds
|
|
FR2953520B1
(fr)
|
2009-12-04 |
2011-11-25 |
Sanofi Aventis |
Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique
|
|
US20130315895A1
(en)
*
|
2010-07-01 |
2013-11-28 |
Takeda Pharmaceutical Company Limited |
COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
|
|
BR112012033402A2
(pt)
|
2010-07-02 |
2017-01-24 |
Gilead Sciences Inc |
moduladores de canais de íons conforme os compostos heterocíclicos fundidos
|
|
WO2012065297A1
(en)
|
2010-11-16 |
2012-05-24 |
Impact Therapeutics, Inc. |
3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
|
|
US9139576B2
(en)
|
2011-05-03 |
2015-09-22 |
Merck Sharp & Dohme Corp. |
Aminomethyl biaryl benzotriazole derivatives
|
|
CA2834164A1
(en)
|
2011-05-10 |
2012-11-15 |
Gilead Sciences, Inc. |
Fused benzoxazinones as ion channel modulators
|
|
NO3175985T3
(https=)
|
2011-07-01 |
2018-04-28 |
|
|
|
CA2849505A1
(en)
|
2011-09-21 |
2013-03-28 |
Gilead Sciences, Inc. |
Sodium channel blockers reduce glucagon secretion
|
|
US9586963B2
(en)
|
2011-09-27 |
2017-03-07 |
Genfit |
Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists
|
|
JP2016511744A
(ja)
|
2012-12-21 |
2016-04-21 |
エピザイム，インコーポレイティド |
Ｐｒｍｔ５を阻害する方法
|
|
RU2015143906A
(ru)
*
|
2013-03-14 |
2017-04-18 |
Дженентек, Инк. |
Замещенные триазолопиридины и способы их применения
|
|
US20140329755A1
(en)
|
2013-05-01 |
2014-11-06 |
Gilead Sciences, Inc. |
Combination therapy for the treatment of arrhythmias or heart failure
|
|
CA2915838C
(en)
|
2013-06-21 |
2023-04-18 |
Zenith Epigenetics Corp. |
Bicyclic bromodomain inhibitors
|
|
DK3035926T3
(da)
|
2013-08-19 |
2020-08-31 |
Univ California |
Forbindelser og fremgangsmåder til behandling af en epilepsilidelse
|
|
GB201321740D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
AU2014364783B2
(en)
|
2013-12-19 |
2017-01-05 |
Gilead Sciences, Inc. |
Fused heterocyclic compounds as ion channel modulators
|
|
WO2015157955A1
(en)
|
2014-04-17 |
2015-10-22 |
Abbvie Inc. |
Heterocyclic btk inhibit ors
|
|
ES2912073T3
(es)
|
2014-06-20 |
2022-05-24 |
Mitsubishi Chem Corp |
Policarbonatodiol, método para producir el mismo, y poliuretano producido usando el mismo
|
|
TWI713455B
(zh)
|
2014-06-25 |
2020-12-21 |
美商伊凡克特治療公司 |
ＭｎＫ抑制劑及其相關方法
|
|
KR101819433B1
(ko)
|
2014-06-26 |
2018-01-16 |
에프. 호프만-라 로슈 아게 |
인돌린-2-온 또는 피롤로-피리딘-2-온 유도체
|
|
JP2017001991A
(ja)
|
2015-06-11 |
2017-01-05 |
大日本住友製薬株式会社 |
新規ベンズオキサゾロン化合物
|
|
WO2018013430A2
(en)
|
2016-07-12 |
2018-01-18 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus infection
|
|
TW201819376A
(zh)
|
2016-10-06 |
2018-06-01 |
比利時商健生藥品公司 |
經取代之１Ｈ－咪唑並［４，５－ｂ］吡啶－２（３Ｈ）－酮及其作為ＧＬＵＮ２Ｂ受體調節劑之用途
|
|
DK3548033T3
(da)
|
2016-11-28 |
2024-07-15 |
Praxis Prec Medicines Inc |
Forbindelser og deres fremgangsmåde til anvendelse
|
|
US11261188B2
(en)
|
2016-11-28 |
2022-03-01 |
Praxis Precision Medicines, Inc. |
Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel
|
|
US20210188839A1
(en)
|
2016-11-28 |
2021-06-24 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
US11492345B2
(en)
|
2017-02-13 |
2022-11-08 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
WO2018187480A1
(en)
|
2017-04-04 |
2018-10-11 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
WO2019035951A1
(en)
|
2017-08-15 |
2019-02-21 |
Praxis Precision Medicines, Inc. |
COMPOUNDS AND THEIR METHODS OF USE
|
|
EA201991306A1
(ru)
|
2017-08-30 |
2020-03-20 |
Праксис Пресижн Медсинз, Инк. |
Соединения и способы их применения
|
|
WO2019232209A1
(en)
*
|
2018-05-30 |
2019-12-05 |
Praxis Precision Medicines, Inc. |
Ion channel modulators
|
|
EA202092908A1
(ru)
|
2018-09-28 |
2021-05-14 |
Праксис Пресижн Медсинз, Инк. |
Модуляторы ионных каналов
|
|
US11773099B2
(en)
|
2019-05-28 |
2023-10-03 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
US11505554B2
(en)
|
2019-05-31 |
2022-11-22 |
Praxis Precision Medicines, Inc. |
Substituted pyridines as ion channel modulators
|
|
US11279700B2
(en)
|
2019-05-31 |
2022-03-22 |
Praxis Precision Medicines, Inc. |
Ion channel modulators
|
|
US11767325B2
(en)
|
2019-11-26 |
2023-09-26 |
Praxis Precision Medicines, Inc. |
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
|
|
EP4065124A4
(en)
|
2019-11-26 |
2023-12-06 |
Praxis Precision Medicines, Inc. |
ION CHANNEL MODULATORS
|
|
US12552797B2
(en)
|
2019-11-27 |
2026-02-17 |
Praxis Precision Medicines, Inc. |
Process for making (3-[cyclopropylethoxy(difluoro)methyl]-6-6[5-fluoro-6-(2,2,2-trifluoroethoxy-3-pyridyl]- [1,2,4]triazolo[4,3-a]pyrazine
|